Skip to content

The study is being done to see whether probiotic (good bacteria) if given to children with autism spectrum disorder has any role to play in improving behaviour and gastro-intestinal symptoms in children

A randomised placebo controlled trial to study the impact of probiotic supplementation on behavioural and gastro-intestinal symptoms in children aged 2-9 years with autism spectrum disorder from Delhi NCR clinics

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/11/038213
Enrollment
180
Registered
2021-11-23
Start date
Unknown
Completion date
Unknown
Last updated
2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F840- Autistic disorder

Interventions

Intervention1: Brain Biome Probiotic supplement: one sachet orally twice daily for 3 months Control Intervention1: Placebo: one sachet orally twice a day for 3 months

Sponsors

Nutri Newron Pediatrix Private limited
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All children between the ages of 2-9 years with autism spectrum disorder diagnosed with DSM 5 criteria All parents who have willingly given an informed written consent

Exclusion criteria

Exclusion criteria: Brian abnormalities detected by neurological imaging procedures Neurological syndromes or focal neurological signs history of documented sequelae of birth asphyxia or preterm less than 28 weeks gestational age or perinatal injury epilepsy -past or current significant sensory impairments like deafness/blindness use of antibiotics within 2 months prior to enrolment Chronic medical conditions Eg Diabetes, weight and height less than 3rd centile for age, long term use of anti inflammatory use within 2 months prior to enrolment Organic GI disorders like Gastro-esophageal reflux, inflammatory bowel disease or prior bowel surgery

Design outcomes

Primary

MeasureTime frame
Comparison of children before probiotic/placebo supplementation by Social responsiveness scale 2, Aberrant behaviour checklist, Gastro-intestinal severity index, Children sleep habits questionnaireTimepoint: at the time of initiation and after 3 months of intervention

Secondary

MeasureTime frame
nilTimepoint: nil

Countries

India

Contacts

Public ContactDr Himani Narula Khanna

Hamdard Institue of Medical Science and Research

roy.sushovan@gmail.com9891274429

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026